Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

Two female Healthcare Professionals (HCPs) in lab coats reviewing glowing digital data and medical information on a screen, demonstrating a modern, high-tech approach to community and collaboration

Building a Better Bridge: Why a Dedicated Community is the Future of HCP Engagement

October 7, 2025

In the battle for HCP attention, the loudest voice doesn't win—the most trusted one does.

The Missing Link: Marrying Clinical Data with Patient Insights

September 30, 2025

Discover how connecting hard data with human experience is the key to unlocking richer provider-patient conversations and stronger brand advocacy.

A Catalyst for Connection: How a Crackdown on DTC Ads Could Transform Pharma Ads to Better Serve Patients

September 24, 2025

The future of health advertising belongs to thoughtful, digitally-driven, opted-in media and specialized content that prioritizes patient education and advocacy above all else.

Beyond the Status Quo: Why HCPs Need Content Delivered Differently

September 22, 2025

Your current content strategy is likely failing to reach overwhelmed HCPs—here's why and how to adapt.

HIV Patient-Reported Survey Data

December 7, 2020

New survey data shows 90% of people living with HIV feel controlled on their current treatment plan, but continue to struggle with great challenges.

Cystic Fibrosis Patient-Reported Survey Data

November 24, 2020

Cystic fibrosis survey data reveals that many people living with CF are hopeful and optimistic, yet the future is unknown.

Parkinson’s Disease Patient-Reported Survey Data

November 23, 2020

New Health Union survey data reveals interesting differences in the patient journeys of men and women living with Parkinson’s disease.

Spondyloarthritis Patient-Reported Survey Data

November 18, 2020

Survey data uncovers the often difficult spondyloarthritis diagnosis journey, showing that 83% of respondents with nr-AxSpA were initially misdiagnosed.

Healthcare Industry Thought Leadership

Contact